Dr. David E Berry , DO
Pediatrics • Blacksburg, VA
817 Davis St Ste A
Blacksburg, VA 240607004
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on April 17, 2006; this date does not establish years in practice.
-
Published CMS data list 91 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Montelukast Sodium — 16 prescription fills, including refills.
- Duloxetine Hcl — 15 prescription fills, including refills.
- Gabapentin — 12 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 7 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 65% of clinicians listed under Pediatrics in Virginia (2024, 35 clinicians with data). Median for this group: 46. Middle half: 21 to 205.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 66 in 2020 to 91 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
817 Davis St Ste A
Blacksburg, VA 240607004
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Pediatrics: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
95 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,769 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $483.87 across 31 records.
By nature of payment
- Food and Beverage: $483.87 across 31 records.
Reporting-company totals (3 largest of 8)
- Supernus Pharmaceuticals, Inc.: $165.58 across 14 records.
- Collegium Pharmaceutical, Inc.: $154.18 across 9 records.
- Merck Sharp & Dohme LLC: $64.26 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Berry has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Berry as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Blacksburg and Virginia
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 65% of clinicians listed under Pediatrics in Virginia (2024, 35 clinicians with data). Median for this group: 46. Middle half: 21 to 205.
Too few clinicians listed under Pediatrics in Blacksburg have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 65% of clinicians listed under Pediatrics in Virginia (2024, 35 clinicians with data). Median for this group: $928. Middle half: $272 to $6,808.
Too few clinicians listed under Pediatrics in Blacksburg have Medicare Part D data for 2024 to compare.
7 active clinicians are listed under Pediatrics with a practice address in Blacksburg, VA (2,002 in Virginia).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 38% from 66 in 2020 to 91 in 2024.
- 2020: 66
- 2021: 53
- 2022: 44
- 2023: 45
- 2024: 91
-
30-day fills
30-day fills increased 28% from 74 in 2020 to 95 in 2024.
- 2020: 74
- 2021: 69
- 2022: 62
- 2023: 57
- 2024: 95
-
Part D drug cost
Part D drug cost went from $475 in 2020 to $2,769 in 2024.
- 2020: $475
- 2021: $757
- 2022: $5,259
- 2023: $7,263
- 2024: $2,769
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $634.80 in 2021 to $483.87 in 2025.
- 2021: $634.80
- 2022: $519.94
- 2023: $554.19
- 2024: $239.03
- 2025: $483.87
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 31 records totaling $483.87.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
GARDASIL 9 | General | $32.13 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
VAXNEUVANCE | General | $32.13 |
| Collegium Pharmaceutical, Inc. |
Food and Beverage
Cash or cash equivalent
|
Jornay PM | General | $23.85 |
| Supernus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Qelbree | General | $23.12 |
| Supernus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Qelbree | General | $22.55 |
| Collegium Pharmaceutical, Inc. |
Food and Beverage
Cash or cash equivalent
|
Jornay PM | General | $22.29 |
| Ultragenyx Pharmaceutical Inc. |
Food and Beverage
In-kind items and services
|
Crysvita | General | $21.19 |
| Phadia US Inc. |
Food and Beverage
Cash or cash equivalent
|
ImmunoCAP | General | $20.92 |
| Collegium Pharmaceutical, Inc. |
Food and Beverage
Cash or cash equivalent
|
Jornay PM | General | $20.51 |
| Ultragenyx Pharmaceutical Inc. |
Food and Beverage
In-kind items and services
|
Crysvita | General | $20.08 |
| Supernus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Qelbree | General | $17.81 |
| Collegium Pharmaceutical, Inc. |
Food and Beverage
Cash or cash equivalent
|
Jornay PM | General | $17.59 |
| Supernus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Qelbree | General | $15.90 |
| Collegium Pharmaceutical, Inc. |
Food and Beverage
Cash or cash equivalent
|
Jornay PM | General | $15.57 |
| Collegium Pharmaceutical, Inc. |
Food and Beverage
Cash or cash equivalent
|
Jornay PM | General | $15.22 |
| ARS Pharmaceuticals Operations, Inc. |
Food and Beverage
In-kind items and services
|
NEFFY | General | $15.10 |
| Supernus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Qelbree | General | $14.93 |
| Collegium Pharmaceutical, Inc. |
Food and Beverage
Cash or cash equivalent
|
Jornay PM | General | $14.90 |
| Supernus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Qelbree | General | $14.05 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
BEXSERO | General | $14.03 |
| Collegium Pharmaceutical, Inc. |
Food and Beverage
Cash or cash equivalent
|
Jornay PM | General | $12.24 |
| Supernus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Qelbree | General | $12.23 |
| Collegium Pharmaceutical, Inc. |
Food and Beverage
Cash or cash equivalent
|
Jornay PM | General | $12.01 |
| Supernus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Qelbree | General | $9.80 |
| Corium, LLC |
Food and Beverage
In-kind items and services
|
Azstarys | General | $8.53 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Montelukast Sodium | Montelukast Sodium | 16 | 600 | $21.03 | — |
| Duloxetine Hcl | Duloxetine Hcl | 15 | 450 | $72.30 | — |
| Gabapentin | Gabapentin | 12 | 360 | $90.61 | — |
| Lorazepam | Lorazepam | 12 | 360 | $22.95 | — |
| Trazodone Hcl | Trazodone Hcl | 12 | 360 | $17.18 | — |
| Promethazine Hcl | Promethazine Hcl | 12 | 360 | $45.14 | — |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | 360 | $2,499.98 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208000000X
A pediatrician is concerned with the physical, emotional and social health of children from birth to young adulthood. Care encompasses a broad spectrum of health services ranging from preventive healthcare to the diagnosis and treatment of acute and chronic diseases. A pediatrician deals with biological, social and environmental influences on the developing child, and with the impact of disease and dysfunction on development.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - PEDIATRIC MEDICINE
I20061205000629
VA
4789683525
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History
NPI enumerated April 17, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Mailing Address
817 Davis St Ste A
Blacksburg, VA 240607004
Phone: 5404433940